OSL oncosil medical ltd

News: OncoSil Medical funded to progress pancreatic cancer device

  1. The Pivotal Clinical Trial for its OncoSil™ localised radiation therapy for the treatment of pancreatic cancer will be supported by OncoSil Medical’s cash and deposits of $7 million at financial year end. The trial has already received Ethics Approval for its Australian sites and validated its manufacturing process.

 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$1.09
Change
-0.020(1.80%)
Mkt cap ! $20.51M
Open High Low Value Volume
$1.11 $1.12 $1.08 $19.98K 18.08K

Buyers (Bids)

No. Vol. Price($)
3 3196 $1.08
 

Sellers (Offers)

Price($) Vol. No.
$1.09 3598 1
View Market Depth
Last trade - 16.10pm 08/08/2025 (20 minute delay) ?
OSL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.